Korea Otsuka Pharmaceutical’s Hyangnam Plant
- A GMP certified facility, Korea Otsuka Pharmaceutical’s Hyangnam plant produces and supplies superior pharmaceuticals based on a production system that is consistent across all processes, from the synthesis of raw materials to the production of finished products. In addition to the domestic supply of products, we have also acquired relevant GMPs in many Asian countries including Japan and have been further expanding our role as Otsuka Pharmaceutical's global production base. In 2014, we expanded our export regions to include Europe in addition to Asia by acquiring EU-GMP, and as such, we are continuing to contribute to the advancement of South Korea’s national economy.
It is no stretch to say that this is the result of the constant efforts we put into investing in developing excellent talent and establishing a production system that has global quality competitiveness by constantly investing the revenue we earned from the sales of pharmaceuticals back into our production equipment in a bid to lay a self-reliant operational foundation in South Korea and to grow into a company that is balanced across the board, from production through to sales.
Going forward, Korea Otsuka Pharmaceutical’s Hyangnam plant will continue to grow together with the Korean people by contributing to their health and striving to improve the quality of the lives of Korean patients suffering from diseases through the stable production and supply of superior medicines while at the same time contributing to the advancement of the national economy
A production facility with global production competitiveness
Established in 1989, Korea Otsuka Pharmaceutical’s Hyangnam plant has acquired relevant GMPs in many Asian countries including Japan, starting with acquiring KGMP (Korea Good Manufacturing Practice). Also, in 2003, when multinational pharmaceutical companies were closing their South Korean factories in droves, Korea Otsuka Pharmaceutical’s Hyangnam plant built a Rebamipide synthesis factory, which was the largest in size in South Korea for manufacturing a single pharmaceutical preparation, further securing its position as Otsuka Pharmaceutical's global production base. In addition, we have world-class technological capabilities that we have acquired through continuous facility investment toward the technological upgrading of our manufacturing equipment and further technification of our processes. We also strive to expand our exports of finished medicinal products and raw medicinal materials and diversify our export regions based on those high quality, technological capabilities. In particular, in 2014, we expanded our export regions to include Europe (21 countries) in addition to Asia (12 countries) through the acquisition of EU-GMP, and as such, we are continuing to contribute to the advancement of South Korea’s national economy. With the acknowledgement of such achievements, we became the first multinational pharmaceutical company to win the 10 Million Dollar Export Tower, in 1998, and the 20 Million Dollar Export Tower, in 2009. We also subsequently won the 30 Million Dollar Export Tower in 2015.
An advanced automation system
Having adopted an automation system for the production of superior medicinal products, we run an optimal production line which has secured safety and reliability in all processes including the synthesis of solid dosage forms (tablets and capsules), liquid dosage forms, dry powder inhalers (DPI), and raw medicinal materials. In addition, we dispatch exceptionally talented individuals overseas each year to acquire more advanced technologies and thereby have established and maintained a world-class pharmaceutical production system.
An impeccable quality control system
We are fully committed to the quality control of all our medicinal products which we manufacture to be the best quality in the world. We also supply medicinal products in South Korea and overseas through a quality management system that is independent across all processes from raw material procurement to production, packaging and shipment by securing state-of-the-art equipment and professional manpower.
A health, safety & environment (HSE) system
Korea Otsuka Pharmaceutical’s Hyangnam plant is working hard to build an eco-friendly production system that also respects humanity as a best partner as it grows together with local communities based on the deep insights and understanding of customers, the market, and society. We adopted HSE as a proactive system that serves to protect workers' health and safety, and the surrounding natural environment from as early as 1996, and having acquired ISO14001 environmental management system certification and OHAS18001 safety and health management system certifications, we are recognized as a leading company in the health and safety environment field.